within Pharmacolibrary.Drugs.ATC.N;

model N02BA11
  extends Pharmacokinetic.Models.PK_2C_enteral(
    weight         = 70,
    F              = 0.8,
    Cl             = 4.5e-05,
    adminDuration  = 600,
    adminMass      = 500 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.00013000000000000002,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0028333333333333335,
    Tlag           = 10.200000000000001,            
    Vdp             = 0.00011,
    k12             = 0.019,
    k21             = 0.019
    
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>N02BA11</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Diflunisal is a nonsteroidal anti-inflammatory drug (NSAID) derived from salicylic acid. It is primarily used for its analgesic and anti-inflammatory properties to manage mild to moderate pain, such as that resulting from arthritis or musculoskeletal injuries. Diflunisal is approved and used in several countries, though it is less commonly prescribed than other NSAIDs today.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters in healthy adult volunteers after single oral administration of diflunisal.</p><h4>References</h4><ol><li><p>Nuernberg, B, et al., &amp; Brune, K (1991). Pharmacokinetics of diflunisal in patients. <i>Clinical pharmacokinetics</i> 20(1) 81–89. DOI:<a href=\"https://doi.org/10.2165/00003088-199120010-00006\">10.2165/00003088-199120010-00006</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/2029803/\">https://pubmed.ncbi.nlm.nih.gov/2029803</a></p></li><li><p>Kizu, J, et al., &amp; Okuda, O (2001). Preparation and clinical application of 2% diflunisal oral ointment for painful lesions of the oral mucosa. <i>Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan</i> 121(11) 829–835. DOI:<a href=\"https://doi.org/10.1248/yakushi.121.829\">10.1248/yakushi.121.829</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/11725552/\">https://pubmed.ncbi.nlm.nih.gov/11725552</a></p></li><li><p>Macdonald, JI, et al., &amp; Verbeeck, RK (1990). Sex-difference and the effects of smoking and oral contraceptive steroids on the kinetics of diflunisal. <i>European journal of clinical pharmacology</i> 38(2) 175–179. DOI:<a href=\"https://doi.org/10.1007/BF00265980\">10.1007/BF00265980</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/2338115/\">https://pubmed.ncbi.nlm.nih.gov/2338115</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end N02BA11;
